(8‐Naphthalen‐1‐ylmethyl‐4‐oxo‐1‐phenyl‐1,3,8‐triaza‐spiro[4.5]dec‐3‐yl)‐acetic acid methyl ester (NNC 63‐0532) is a novel potent nociceptin receptor agonist
- 1 November 2000
- journal article
- Published by Wiley in British Journal of Pharmacology
- Vol. 131 (5) , 903-908
Abstract
Spiroxatrine was identified as a moderately potent (Ki=118 nM) but non‐selective agonist at the human nociceptin/orphanin FQ receptor, ORL1. This compound was subject to chemical modification and one of the resulting compounds, (8‐naphthalen‐1‐ylmethyl‐4‐oxo‐1‐phenyl‐1,3,8‐triaza‐spiro[4.5]dec‐3‐yl)‐acetic acid methyl ester (NNC 63‐0532) was shown to have high affinity for ORL1 (Ki=7.3 nM). NNC 63‐0532 showed only moderate affinity for the following receptors (Ki values in parentheses): μ‐opioid (140 nM), κ‐opioid (405 nM), dopamine D2S (209 nM), dopamine D3 (133 nM) and dopamine D4.4 (107 nM) out of 75 different receptors, ion‐channels and transporters. In functional assays, NNC 63‐0532 was shown to be an agonist at ORL1 (EC50=305 nM), a much weaker agonist at the μ‐opioid receptor (EC50>10 μM) and an antagonist or weak partial agonist at dopamine D2S (IC50=2830 nM). Thus, NNC 63‐0532 is a novel non‐peptide agonist with ∼12 fold selectivity for ORL1 and may be useful for exploring the physiological roles of this receptor owing to its brain‐penetrating properties. British Journal of Pharmacology (2000) 131, 903–908; doi:10.1038/sj.bjp.0703661Keywords
This publication has 19 references indexed in Scilit:
- Kinetics versus equilibrium: the importance of GTP in GPCR activationTrends in Pharmacological Sciences, 1999
- Discovery of the First Potent and Selective Small Molecule Opioid Receptor-like (ORL1) Antagonist: 1-[(3R,4R)-1-Cyclooctylmethyl-3- hydroxymethyl-4-piperidyl]-3-ethyl- 1,3-dihydro-2H-benzimidazol-2-one (J-113397)Journal of Medicinal Chemistry, 1999
- Agonistic Effect of Buprenorphine in a Nociceptin/OFQ Receptor-Triggered Reporter Gene AssayMolecular Pharmacology, 1999
- Nociceptin (Orphanin FQ): High-Affinity and High-Capacity Binding Site Coupled to Low-Potency Stimulation of Guanylyl-5′-O-(γ-thio)-triphosphate Binding in Rat Brain MembranesThe Journal of Pharmacology and Experimental Therapeutics, 1998
- The preferential dopamine D3 receptor agonist cis-8-OH-PBZI induces limbic Fos expression in rat brainEuropean Journal of Pharmacology, 1997
- Recognition and activation of the opioid receptor-like ORL1 receptor by nociceptin, nociceptin analogs and opioidsEuropean Journal of Pharmacology, 1997
- L-2-amino-4-phosphonobutyrate (L-AP4) is an agonist at the type iv metabotropic glutamate receptor which is negatively coupled to adenylate cyclaseEuropean Journal of Pharmacology: Molecular Pharmacology, 1992
- Differential Effects of Mg2+ and Other Divalent Cations on the Binding of Tritiated Opioid LigandsJournal of Neurochemistry, 1992
- Pharmacological profiles of fentanyl analogs at μ, δ and κ opiate receptorsEuropean Journal of Pharmacology, 1992
- An improved method for anchoring of 9-fluorenylmethoxycarbonyl-amino acids to 4-alkoxybenzyl alcohol resins.Tetrahedron Letters, 1987